Research/Clinical Trials at current location-Partial List- call 4137475566 for information

01

EMBRACE-ViiV Healthcare- A Phase 2b Multicenter, Randomized, Open-Label Study Comparing the Efficacy, Safety, PK, and Tolerability of VH3810109, Administered Either Intravenously Or As A Subcutaneous Infusion with rHuPH20, in Combination with CAB LA to Standard of Care in Virologically Suppressed Adults Living with HIV.

02

Artistry 2- Phase 3 Double-blind Multicenter Randomized Active-Controlled Study to Evaluate the Safety and Efficacy to Bictegravir/Lenacapavir Versus Biktarvy in Virologically Suppressed People with HIV-1 Infection- GS-US-6216290

03

TH-IBA-CTR-1003- Theratechnologies-A Prospective and Retrospective Observational Study of Multidrug-Resistant Patient Outcomes With and Without Ibalizumab (PROMISE-US). ClinicalTrials.gov ID NCT05388474

04

BTZ116577- A Study Evaluating Efficacy and Safety of Gepotidacin Compared With Ceftriaxone Plus Azithromycin in the Treatment of Uncomplicated Urogenital Gonorrhea

05EB-P30-01

A Randomized, Double-Blind, Sham Controlled,Stratified, Pivotal Efficacy and Safety Study of the EmitBio RD-X19 Treatment Device in Individuals 40 Years of Age and Older with Mild COVID-19 in the At-Home Setting (Pro00069215)

07